Is Hilan (TASE:HLAN) Expensive Following Earnings Growth And Its Dividend Decision?

Hilan’s latest earnings and dividend decision

Hilan (TASE:HLAN) reported second quarter and first half 2026 results alongside a fresh dividend announcement, giving investors updated figures on profitability and a new cash return per share to factor into their decisions.

See our latest analysis for Hilan.

Hilan’s recent earnings and dividend announcement have come as the share price has moved to ₪229.7, with a 9.49% 1 month share price return but a year to date share price return that is down 13.39%. Over a longer horizon, the 5 year total shareholder return of 35.10% indicates investors who stayed invested over several years have seen a different experience to those focused only on recent moves.

If you want to broaden your search beyond Hilan and see what else is moving, this is a good moment to scan 113 top founder-led companies

For Hilan, the recent rebound sits against a weaker year to date picture, which leaves one key issue: Are investors now reacting to the company’s latest earnings and dividend, or is sentiment doing most of the work?

Price to earnings of 19.5x for Hilan: Is it justified?

Hilan is trading on a P/E of 19.5x compared to a last close of ₪229.7, while peers and the wider Asian Professional Services industry sit at lower levels.

The P/E ratio compares the current share price to earnings per share. For a company like Hilan that reports high quality earnings, this measure helps you see how much the market is paying for each unit of profit.

Hilan currently has a P/E of 19.5x, which is above the peer average of 18.9x and also above the Asian Professional Services industry average of 15.3x. That higher multiple suggests investors are paying a premium relative to both direct peers and the broader industry, even though recent earnings growth of 5.7% over the past year is below the 10.9% recorded by the Professional Services industry and below Hilan’s own 5 year average earnings growth of 13.9% per year.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-earnings of 19.5x (OVERVALUED)

However, Hilan’s higher P/E and its focus on Israel, where almost all revenue is generated, could leave the stock exposed if sector conditions or local demand weaken.

Find out about the key risks to this Hilan narrative.

Another view on Hilan’s valuation

The P/E ratio presents Hilan as expensive compared to peers, yet the SWS DCF model suggests a different story. At a share price of ₪229.7, the model estimates fair value at ₪287.52, which implies the stock is trading at a discount. Which signal should be treated as more important?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hilan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 266 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

After weighing the mixed signals around Hilan’s valuation and recent performance, it makes sense to review the details yourself and act while the information is fresh. To see what investors view as the key positives, take a closer look at 2 key rewards

Looking for more investment ideas beyond Hilan?

If Hilan is on your radar, this is the right moment to widen your research and line up a few more candidates that could strengthen your portfolio.

• Target steadier cash flows by reviewing companies with stronger fundamentals and lower leverage through the solid balance sheet and fundamentals stocks screener (427 results).
• Hunt for potential value opportunities that pair quality metrics with pricing that looks more conservative using the 266 high quality undervalued stocks.
• Position your portfolio for resilience by scanning companies that score well on stability and risk using the 292 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com